Literature DB >> 19218407

Spontaneous quinolone resistance in the zoonotic serovar of Vibrio vulnificus.

Francisco J Roig1, A Llorens, B Fouz, C Amaro.   

Abstract

This work demonstrates that Vibrio vulnificus biotype 2, serovar E, an eel pathogen able to infect humans, can become resistant to quinolone by specific mutations in gyrA (substitution of isoleucine for serine at position 83) and to some fluoroquinolones by additional mutations in parC (substitution of lysine for serine at position 85). Thus, to avoid the selection of resistant strains that are potentially pathogenic for humans, antibiotics other than quinolones must be used to treat vibriosis on farms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19218407      PMCID: PMC2675197          DOI: 10.1128/AEM.02921-08

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  28 in total

1.  EUCAST Definitive Document E.DEF 2.1, August 2000: Determination of antimicrobial susceptibility test breakpoints.

Authors: 
Journal:  Clin Microbiol Infect       Date:  2000-10       Impact factor: 8.067

2.  EUCAST Definitive Document E.DEF 3.1, June 2000: Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution.

Authors: 
Journal:  Clin Microbiol Infect       Date:  2000-09       Impact factor: 8.067

3.  gyrA and parC associated with quinolone resistance in Vibrio anguillarum.

Authors:  C Rodkhum; T Maki; I Hirono; T Aoki
Journal:  J Fish Dis       Date:  2008-05       Impact factor: 2.767

4.  Field testing of a vaccine against eel diseases caused by Vibrio vulnificus.

Authors:  B Fouz; M D Esteve-Gassent; R Barrera; J L Larsen; M E Nielsen; C Amaro
Journal:  Dis Aquat Organ       Date:  2001-08-02       Impact factor: 1.802

5.  Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance.

Authors:  T Akasaka; M Tanaka; A Yamaguchi; K Sato
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

6.  Transmission to eels, portals of entry, and putative reservoirs of Vibrio vulnificus serovar E (biotype 2).

Authors:  E Marco-Noales; M Milán; B Fouz; E Sanjuán; C Amaro
Journal:  Appl Environ Microbiol       Date:  2001-10       Impact factor: 4.792

7.  In vitro susceptibility of Vibrio spp. isolated from the environment.

Authors:  S Zanetti; T Spanu; A Deriu; L Romano; L A Sechi; G Fadda
Journal:  Int J Antimicrob Agents       Date:  2001-05       Impact factor: 5.283

8.  Comparative genome analysis of Vibrio vulnificus, a marine pathogen.

Authors:  Chung-Yung Chen; Keh-Ming Wu; Yo-Cheng Chang; Chuan-Hsiung Chang; Hui-Chi Tsai; Tsai-Lien Liao; Yen-Ming Liu; Hsiang-Ju Chen; Arthur Bo-Ting Shen; Jian-Chiuan Li; Teh-Li Su; Chung-Ping Shao; Chung-Te Lee; Lien-I Hor; Shih-Feng Tsai
Journal:  Genome Res       Date:  2003-12       Impact factor: 9.043

9.  Characterization and pathogenic significance of Vibrio vulnificus antigens preferentially expressed in septicemic patients.

Authors:  Young Ran Kim; Shee Eun Lee; Choon Mee Kim; Soo Young Kim; Eun Kyoung Shin; Dong Hyeon Shin; Sun Sik Chung; Hyon E Choy; Ann Progulske-Fox; Jeffrey D Hillman; Martin Handfield; Joon Haeng Rhee
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

Review 10.  Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection.

Authors:  Joaquim Ruiz
Journal:  J Antimicrob Chemother       Date:  2003-04-14       Impact factor: 5.790

View more
  2 in total

1.  Genetic characterization of Vibrio vulnificus strains from tilapia aquaculture in Bangladesh.

Authors:  Zahid H Mahmud; Anita C Wright; Shankar C Mandal; Jianli Dai; Melissa K Jones; Mahmud Hasan; Mohammad H Rashid; Mohammad S Islam; Judith A Johnson; Paul A Gulig; J Glenn Morris; Afsar Ali
Journal:  Appl Environ Microbiol       Date:  2010-05-21       Impact factor: 4.792

2.  Prevalence, Genetic Diversity, Antimicrobial Resistance, and Toxigenic Profile of Vibrio vulnificus Isolated from Aquatic Environments in Taiwan.

Authors:  I-Ching Lin; Bashir Hussain; Bing-Mu Hsu; Jung-Sheng Chen; Yu-Ling Hsu; Yi-Chou Chiu; Shih-Wei Huang; Jiun-Ling Wang
Journal:  Antibiotics (Basel)       Date:  2021-04-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.